LONDON, May 10, 2026 — Kalshi, the first federally regulated prediction market exchange in the United States, has closed a $1 billion Series F funding round at a $22 billion valuation, doubling its worth in fewer than five months. The round, led by Coatue Management with participation from Sequoia, Andreessen Horowitz (a16z), IVP, Paradigm, Morgan Stanley, and ARK Invest, represents one of the largest private capital injections into a financial infrastructure company this year. Annualised revenue at Kalshi now exceeds $1.5 billion, while institutional trading volume has surged 800 per cent in six months, according to figures reported by TechFundingNews on 8 May 2026. The raise marks Kalshi's third funding round in just seven months, a cadence typically reserved for companies on a direct path to public listing. This analysis, part of Business20Channel.tv's ongoing coverage of AI-driven financial infrastructure, examines the capital strategy behind this round, the competitive dynamics between Kalshi and Polymarket, and the broader implications for institutional adoption of event-contract markets.

Executive Summary

• Funding: Kalshi raised $1 billion in a Series F at a $22 billion valuation, led by Coatue, with Sequoia, a16z, IVP, Paradigm, Morgan Stanley, and ARK Invest participating.
• Valuation trajectory: The company's valuation doubled from $11 billion in December 2025, with this being its third raise in seven months.
• Revenue scale: Annualised revenue now exceeds $1.5 billion; annualised trading volume has grown from $52 billion to $178 billion in six months.
• Institutional pivot: Institutional trading volume rose 800 per cent in six months, with capital earmarked for broker integrations, risk products, and block-trading tools.
• Competitive position: Kalshi claims over 90 per cent of US prediction market activity and majority global volume, while rival Polymarket is blocked from the US market.

Key Developments

A Third Round in Seven Months

Kalshi's fundraising velocity is extraordinary by any standard in financial technology. In December 2025, the company raised at an $11 billion valuation. Fewer than five months later, it has doubled that figure to $22 billion. The $1 billion Series F, announced on 8 May 2026, was led by Coatue Management, the New York-based technology investment firm that has increasingly deployed capital into alternative financial platforms. The investor syndicate reads as a who's who of Silicon Valley and Wall Street convergence: Sequoia Capital, Andreessen Horowitz, IVP, Paradigm, Morgan Stanley, and ARK Invest. The participation of Morgan Stanley, a bulge-bracket investment bank, alongside crypto-native Paradigm and Cathie Wood's ARK Invest, signals that event-contract markets are no longer treated as a niche product category but as core financial infrastructure.

From Regulatory Battle to Revenue Machine

Founded in 2018 by MIT graduates Tarek Mansour and Luana Lopes Lara, Kalshi spent its early years locked in a protracted legal battle with the Commodity Futures Trading Commission (CFTC) over the legal right to operate event-contract markets in the United States. That fight, which consumed years and significant capital, has now become the company's most defensible competitive advantage — a regulatory moat that bars unregistered rivals from offering prediction contracts to US users. The platform's annualised revenue surpassing $1.5 billion represents a dramatic commercialisation of what was, until recently, a largely consumer-driven product. Annualised trading volume has more than tripled from $52 billion to $178 billion in six months, according to company disclosures cited by TechCrunch. Kalshi now claims more than 90 per cent of all US prediction market activity and the majority of global volume — a dominance that justifies the premium valuation.

Institutional Capital as the Growth Engine

The 800 per cent increase in institutional trading volume over six months is the single most important metric in this round. Hedge funds, asset managers, proprietary trading firms, and insurers are increasingly using event contracts not as speculative instruments but as real-time hedging and sentiment-tracking tools. The new $1 billion in capital will be deployed to expand broker integrations, build risk-focused products, and scale recently launched block-trading capabilities designed for larger investors. This institutional tilt differentiates Kalshi from consumer-oriented prediction platforms and aligns it more closely with traditional derivatives exchanges like CME Group or Cboe Global Markets, which generate the bulk of revenue from institutional flow.

Market Context & Competitive Landscape

Kalshi vs. Polymarket: A Regulatory Divide

The prediction market sector is consolidating rapidly around two dominant players, and the competitive dynamics are shaped almost entirely by regulation. Polymarket, Kalshi's largest rival, commands significant international volume but remains blocked from the US market — the world's deepest pool of institutional capital. Polymarket is reportedly raising $400 million at a $15 billion valuation, roughly a third below Kalshi's current $22 billion figure. That gap is not merely a function of revenue; it reflects the value investors assign to regulatory clearance in the most lucrative financial jurisdiction on earth.

Source: TechFundingNews, 8 May 2026; TechCrunch reports. *Polymarket figures reported but unconfirmed as of publication.

Broader Competitive Benchmarks

Beyond Polymarket, Kalshi's valuation and revenue trajectory invite comparison with established derivatives infrastructure. CME Group, the world's largest derivatives exchange, reported $5.6 billion in revenue for 2025, according to its investor relations filings. Cboe Global Markets reported approximately $3.8 billion. Kalshi's $1.5 billion annualised revenue, if sustained, would place it within striking distance of these incumbents — a remarkable position for a company that did not exist eight years ago. However, investors should note that Kalshi's revenue is self-reported and the company remains private, meaning these figures have not been subjected to independent audit. The sustainability of triple-digit volume growth also warrants scrutiny, particularly if macroeconomic or political catalysts that drive event-contract trading — such as US elections — recede in intensity.

Source: CME Group and Cboe investor filings (2025); TechFundingNews and TechCrunch for Kalshi and Polymarket figures, May 2026. *Polymarket valuation reported, not confirmed.

Industry Implications

Finance and Insurance: Hedging in Real Time

The most consequential implication of Kalshi's institutional surge is in financial services. Hedge funds and asset managers are now using event contracts as real-time proxies for probability-weighted risk — a function traditionally served by options markets and credit default swaps. Insurers, too, are exploring event contracts as hedging tools for catastrophe risk, political risk, and regulatory change. The 800 per cent increase in institutional volume reported by Kalshi suggests this is no longer experimental; it is becoming operational. For banks such as Morgan Stanley — itself an investor in this round — event-contract data offers a new layer of market intelligence. If Kalshi's annualised trading volume of $178 billion is accurate, the platform is generating pricing signals that rival traditional sentiment indicators like the VIX or credit-default-swap spreads.

Government, Legal, and Policy Verticals

Prediction markets carry profound implications for government policy analysis and legal risk assessment. In 2025, the US intelligence community IARPA continued to explore aggregated forecasting as a supplement to traditional intelligence analysis. Kalshi's regulated status under the CFTC gives its data a degree of institutional credibility that unregulated platforms cannot match. For the legal sector, event contracts tied to regulatory outcomes — such as the probability of specific FDA approvals or antitrust rulings — create a new class of information product. Law firms and compliance departments at Fortune 500 companies could increasingly reference prediction market pricing as evidence of market consensus, provided the data is generated on a regulated exchange. The healthcare sector, where clinical trial outcomes and drug approval timelines carry billions in market capitalisation implications, represents a largely untapped vertical for event-contract products.

Business20Channel.tv Analysis

The Regulatory Moat Is the Valuation

Our assessment at Business20Channel.tv is that investors in this round are not primarily buying revenue growth — they are buying the regulatory moat. Kalshi's years-long battle with the CFTC, which many observers initially viewed as an existential risk, has become the company's most potent barrier to entry. No competitor can replicate this advantage without enduring a similar multi-year regulatory process, and the CFTC has shown no inclination to fast-track approvals. This is precisely why Polymarket, despite commanding significant international volume, trades at a $7 billion discount to Kalshi. The US market — with its depth of institutional capital, its legal protections for contract enforcement, and its role as the default jurisdiction for global asset managers — is uniquely valuable for a prediction exchange. Kalshi owns that market. The 90 per cent US market share figure, if accurate, is not just dominant; it is effectively monopolistic.

What the Consensus Is Missing: IPO Cadence

Three funding rounds in seven months is not a typical venture capital pattern. It is an IPO preparation pattern. The rapid capital accumulation, combined with the deliberate inclusion of Morgan Stanley — a top-three US IPO underwriter — in the investor syndicate, strongly suggests Kalshi is building the capital base, institutional relationships, and revenue track record required for a public listing within the next 12 to 18 months. A $22 billion private valuation implies that a public offering at a $30–40 billion market capitalisation is plausible if revenue growth holds. That would make Kalshi one of the largest fintech IPOs of 2027, rivalling the Coinbase direct listing of 2021 in scale and significance.

Risks That Deserve Scrutiny

We must note several material risks. First, Kalshi's revenue figures are self-reported and unaudited. Private company claims of annualised revenue and trading volume deserve healthy scepticism until validated by independent audit or public filings. Second, prediction market volume is highly event-dependent. US presidential elections, Federal Reserve policy shifts, and geopolitical crises drive surges in event-contract activity; quieter periods may reveal whether the institutional adoption is structural or cyclical. Third, the CFTC's regulatory posture could shift. A change in administration or CFTC leadership could alter the regulatory framework, potentially opening the US market to competitors or imposing new restrictions on the types of contracts Kalshi can list. The Business20Channel.tv editorial team will continue to monitor these dynamics closely.

Why This Matters for Industry Stakeholders

For institutional investors considering allocation to prediction market platforms, this round establishes a clear valuation benchmark: $22 billion for a regulated US exchange with $1.5 billion in annualised revenue and $178 billion in annualised trading volume. The implied revenue multiple of approximately 14.7x is aggressive but not unprecedented for high-growth financial infrastructure — Coinbase traded at similar multiples in its early public trading in 2021. Asset managers who are not yet trading event contracts should consider that 800 per cent institutional volume growth in six months suggests a structural shift, not a fad. The question is no longer whether prediction markets will attract institutional capital, but how quickly the product suite will expand to cover more granular risk exposures — from individual company earnings outcomes to sovereign credit events.

For fintech founders and early-stage companies, Kalshi's trajectory offers a critical lesson: regulatory advantage, even when costly and slow to acquire, can generate more durable competitive advantage than technology alone. The company's multi-year CFTC battle is now worth billions in enterprise value. For regulators themselves, Kalshi's success — and the $1 billion in private capital flowing into a CFTC-regulated entity — validates the approach of creating clear legal frameworks for novel financial products rather than banning them outright. The European Union, the United Kingdom, and Singapore should take note.

Forward Outlook

The next 12 months will determine whether Kalshi can sustain its current trajectory or whether the extraordinary growth metrics of 2025–2026 represent a peak driven by unique macroeconomic and political catalysts. We anticipate three key developments. First, an IPO filing or pre-IPO capital raise in 2027 appears highly probable, given the fundraising cadence and the strategic inclusion of Morgan Stanley. Second, Kalshi will likely expand its product suite into more complex event-contract structures — potentially including multi-leg contracts, conditional contracts, and index-linked event products — to deepen institutional engagement. Third, Business20Channel.tv expects the CFTC to face increasing pressure to define its approach to international prediction market operators like Polymarket, which currently operate in a regulatory grey zone outside the US. How the CFTC resolves this question will shape the competitive landscape for the next decade. The open question is not whether prediction markets have arrived — they have. The question is whether $22 billion accurately prices the risk that this market's explosive growth may slow as the political and macroeconomic events that fuelled it become less frequent. Founders Tarek Mansour and Luana Lopes Lara have built one of the most valuable private financial companies in the world in just eight years. What happens next — IPO, acquisition, or a more sobering encounter with mean reversion — will define not just Kalshi, but the entire prediction market category.

Key Takeaways

• Valuation doubled: Kalshi's $22 billion valuation represents a 100 per cent increase from the $11 billion figure set in December 2025, following its $1 billion Series F led by Coatue.
• Revenue at scale: Annualised revenue exceeding $1.5 billion and annualised trading volume of $178 billion — up from $52 billion six months prior — signal rapid institutional adoption.
• Regulatory moat is decisive: CFTC regulation gives Kalshi exclusive access to the US market, where it claims over 90 per cent market share, while Polymarket remains blocked from US operations.
• IPO signals are strong: Three funding rounds in seven months, combined with Morgan Stanley's participation as an investor, suggest a public listing within 12–18 months is likely under consideration.
• Risks remain material: Self-reported revenue figures, event-dependent volume cycles, and potential CFTC regulatory shifts warrant continued scrutiny from investors and industry observers.

References & Bibliography

[1] TechFundingNews. (2026, May 8). Kalshi doubles valuation to $22B with $1B raise as Coatue bets on prediction markets. https://techfundingnews.com/kalshi-doubles-valuation-to-22b-with-1b-raise-as-coatue-bets-on-prediction-markets/

[2] TechCrunch. (2026, May 8). Kalshi Series F coverage. https://techcrunch.com/

[3] Coatue Management. (2026). Official website. https://www.coatue.com/

[4] Sequoia Capital. (2026). Official website. https://www.sequoiacap.com/

[5] Andreessen Horowitz (a16z). (2026). Official website. https://a16z.com/

[6] Paradigm. (2026). Official website. https://www.paradigm.xyz/

[7] Morgan Stanley. (2026). Official website. https://www.morganstanley.com/

[8] ARK Invest. (2026). Official website. https://ark-invest.com/

[9] U.S. Commodity Futures Trading Commission (CFTC). (2026). Official website. https://www.cftc.gov/

[10] Polymarket. (2026). Official website. https://polymarket.com/

[11] CME Group. (2025). Annual Report and Investor Relations. https://www.cmegroup.com/investor-relations.html

[12] Cboe Global Markets. (2025). Annual Report and Investor Relations. https://www.cboe.com/

[13] Cboe VIX Index. (2026). VIX Product Page. https://www.cboe.com/tradable_products/vix/

[14] IARPA. (2026). Intelligence Advanced Research Projects Activity. https://www.iarpa.gov/

[15] Coinbase. (2026). Official website. https://www.coinbase.com/

[16] Kalshi. (2026). Official website. https://kalshi.com/

[17] Financial Times. (2026). Prediction markets coverage. https://www.ft.com/

[18] Bloomberg. (2026). Fintech and derivatives coverage. https://www.bloomberg.com/

[19] Reuters. (2026). Financial regulation coverage. https://www.reuters.com/

[20] The Wall Street Journal. (2026). Financial technology coverage. https://www.wsj.com/

[21] Business20Channel.tv. (2026). AI and financial technology coverage. https://business20channel.tv/?category=AI